Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer From Fine Needle Aspirates
Observational
Observational Model: Case-Only, Time Perspective: Prospective
Use of Ribonucleic acid-based molecular signature of tumor samples obtained by fine needle aspirate to discriminate subtypes of tumors relevant to treatment and outcomes.
To test a an 8-gene panel's accuracy in discriminating Non-Small Cell Lung Cancer tumors subtypes that are relevant to treatment and expected outcomes.
Day 1
No
Jimmy Ruiz, MD
Principal Investigator
Wake Forest University
United States: Institutional Review Board
CCCWFU 97112
NCT01630122
June 2012
June 2016
Name | Location |
---|---|
Wake Forest University Health Sciences | Winston-Salem, North Carolina 27157 |